EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus

Irene Santos-Pardo, Mikael Andersson Franko, Bo Lagerqvist, Viveca Ritsinger, Björn Eliasson, Nils Witt, Anna Norhammar, Thomas Nyström

JACC · 2024-07 · 84 (3) · 260-272

DOI: 10.1016/j.jacc.2024.04.012 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift JACC, 2024-07. Verfasst von Irene Santos-Pardo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Science and Education, Karolinska Institutet, Unit of Cardiology, Södersjukhuset, Stockholm, Sweden. Electronic address: irene…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Drug-Eluting Stents, Glycated Hemoglobin, Glycemic Control. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Stockholms Lans Landsting.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The impact of glycemic control in the risk of stent failure in subjects with type 2 diabetes (T2D) is currently unknown. OBJECTIVES: This study sought to study whether poor glycemic control is associated with a higher risk of stent failure in subjects with T2D. METHODS: This observational study included all patients in Sweden with T2D who underwent implantation of second-generation drug-eluting stents (DES) during 2010 to 2020. The exposure variable was the updated mean of glycated hemoglobin (HbA1c). Individuals were stratified by glycemic control, with HbA1c 6.1% to 7.0% (43-53 mmol/mol) as the reference group. The primary endpoint was the occurrence of stent failure (in-stent restenosis and stent thrombosis). The main result was analyzed in a complete cases model. Sensitivity analyses were performed for missing data and a model with death as a competing risk. RESULTS: The study population consisted of 52,457 individuals (70,453 DES). The number of complete cases was 24,411 (29,029 DES). The median follow-up was 6.4 years. The fully adjusted HR was 1.10 (95% CI: 0.80-1.52) for HbA1c of ≤5.5% (≤37 mmol/mol), 1.02 (95% CI: 0.85-1.23) for HbA1c of 5.6% to 6.0% (38-42 mmol/mol), 1.25 (95% CI: 1.11-1.41) for HbA1c of 7.1% to 8.0% (54-64 mmol/mol), 1.30 (95% CI: 1.13-1.51) for HbA1c of 8.1% to 9.0% (65-75 mmol/mol), 1.46 (95% CI: 1.21-1.76) for HbA1c of 9.1% to 10.0% (76-86 mmol/mol), and 1.33 (95% CI: 1.06-1.66) for HbA1c of ≥10.1% (≥87 mmol/mol). Sensitivity analyses did not change the main result. CONCLUSIONS: We found a significant association between poor glycemic control and a higher risk of stent failure driven by in-stent restenosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Drug-Eluting StentsGlycated HemoglobinGlycemic ControlHumansMaleFemaleAgedMiddle AgedSwedenCoronary Artery DiseasePercutaneous Coronary InterventionCoronary RestenosisProsthesis FailureBlood Glucose

Stichwörter der Autor:innen

drug-eluting stentglycated hemoglobinin-stent restenosisstent thrombosistype 2 diabetes

Substanzen

Glycated HemoglobinBlood Glucose

Autor:innen und Institutionen

  • Department of Clinical Science and Education, Karolinska Institutet, Unit of Cardiology, Södersjukhuset, Stockholm, Sweden. Electronic address: irene.santos-pardo@regionstockholm.se.
  • Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden.
  • Department of Medical Sciences, Cardiology Unit, and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
  • Department of Medicine K2, Unit of Cardiology, Karolinska Institutet, Stockholm, Sweden; Department of Research and Development, Region Kronoberg, Växjö, Sweden.
  • Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Department of Clinical Science and Education, Karolinska Institutet, Unit of Cardiology, Södersjukhuset, Stockholm, Sweden.

Förderung

  • Stockholms Lans Landsting

Zitieren

APA

Santos-Pardo, I., Andersson Franko, M., Lagerqvist, B., Ritsinger, V., Eliasson, B., Witt, N., Norhammar, A., & Nyström, T. (2024). Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus. JACC, 84(3), 260-272. https://doi.org/10.1016/j.jacc.2024.04.012

Vancouver

Santos-Pardo I, Andersson Franko M, Lagerqvist B, Ritsinger V, Eliasson B, Witt N, et al. Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus. JACC. 2024;84(3):260-272. doi:10.1016/j.jacc.2024.04.012

BibTeX
@article{SantosPardo2024,
  author = {Santos-Pardo, Irene and Andersson Franko, Mikael and Lagerqvist, Bo and Ritsinger, Viveca and Eliasson, Björn and Witt, Nils and Norhammar, Anna and Nyström, Thomas},
  title = {Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus},
  journal = {JACC},
  year = {2024},
  volume = {84},
  number = {3},
  pages = {260--272},
  doi = {10.1016/j.jacc.2024.04.012}
}
Kostenlos starten →